the evaluation of interferon in human malignancy is just beginning , but some encouraging results have been obtained in open trials of the drug in patients with non-hodgkin 's lymphoma , melanoma , osteogenic sarcoma , and other diseases .
C0006826
malignancy
C0025202
melanoma